Estimation of the predictive role of plasma viral load on CD4 decline in HIV-1 subtype C-infected subjects in India

Journal of Acquired Immune Deficiency Syndromes

Volumn 50, Issue 2, 2009, Pages 119-125

  Ding, Ming ^a   Tarwater, Patrick ^b   Rodriguez, Milka ^a   Chatterjee, Ramdas ^c   Ratner, Deena ^a   Yamamura, Yasuhiro ^d   Roy, Pratima ^e   Mellors, John ^f   Neogi, Dhruba ^e   Chen, Yue ^a   Gupta, Phalguni ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Chittaranjan Cancer Research Institute   (India)

^d PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^e CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CD4 decline; Indian subjects; Plasma HIV load; Real time RT PCR

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ARTICLE; BLOOD ANALYSIS; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ISOLATION; VIRUS LOAD; BLOOD; CD4+ T LYMPHOCYTE; CLASSIFICATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PHYSIOLOGY; PREDICTION AND FORECASTING; VIROLOGY;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; INDIA; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 60749099419     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181911991     Document Type: Article

References (27)

1. Bollinger RC, Tripathy SP, Quinn TC. The human immunodeficiency virus epidemic in India. Current magnitude and future projections. Medicine (Baltimore). 1995;74:97-106.
2. Gupta P, Kingsley L, Sheppard HW, et al. High incidence and prevalence of HIV-I infection in high risk population in Calcutta, India. Int J STD AIDS. 2003;14:463-468.
3. Mehendale SM, Rodrigues JJ, Brookmeyer RS, et al. Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics in India. J Infect Dis. 1995;172:1486-1491.
4. Baskar PV, Ray SC, Rao R, et al. Presence in India of HIV type 1 similar to North American strains. AIDS Res Hum Retroviruses. 1994;10:1039-1041.
5. Delwart EL, Shpaer EG, Louwagie J, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 1993;262:1257-1261.
6. Jameel S, Zafrullah M, Ahmad M, et al. A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants. AIDS. 1995;9:685-690.
7. Maitra A, Singh B, Banu S, et al. Subtypes of HIV type 1 circulating in India: partial envelope sequences. AIDS Res Hum Retroviruses. 1999;15:941-944.
8. Sengupta S, Jana S, Sarkar K, et al. Determination of gag subtypes of HIV type 1 detected among female sex workers in Calcutta, India. AIDS Res Hum Retroviruses. 2005;21:806-809.
9. Shankarappa R, Chatterjee R, Learn GH, et al. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J Virol. 2001;75:10479-10487.
10. Tripathy S, Renjifo B, Wang WK, et al. Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India. AIDS Res Hum Retroviruses. 1996;12:1199-1202.
11. Cecilia D, Kulkarni SS, Tripathy SP, et al. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology. 2000;271:253-258.
12. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126:946-954.
13. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167-1170.
14. Vlahov D, Graham N, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA. 1998;279:35-40.
15. Mehendale SM, Bollinger RC, Kulkarni SS, et al. Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India. AIDS Res Hum Retroviruses. 2002;18:1175-1179.
16. Lyles RH, Munoz A, Yamashita TE, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis. 2000;181:872-880.
17. Mochizuki N, Otsuka N, Matsuo K, et al. An infectious DNA clone of HIV type 1 subtype C. AIDS Res Hum Retroviruses. 1999;15:1321-1324.
18. Rodriguez MA, Chen Y, Craigo JK, et al. Construction and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin. Virology. 2006;345:328-336.
19. O'Marro SD, Armstrong JA, Asuncion C, et al. The effect of combinations of ampligen and zidovudine or dideoxyinosine against human immunodeficiency viruses in vitro. Antiviral Res. 1992;17:169-177.
20. Bachmann MH, Delwart EL, Shpaer EG, et al. Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994;10:1345-1353.
21. Gottesman BS, Grosman Z, Lorber M, et al. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load. J Med Virol. 2004;73:167-171.
22. Calmy A, Pascual F, Ford N. HIV drug resistance. N Engl J Med. 2004;350:2720-2721.
23. Katzenstein D, Laga M, Moatti JP. The evaluation of the HIV/AIDS drug access initiatives in Cote d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa. AIDS. 2003;17:S1-S4.
24. Kamat A, Ravi V Desai A, et al. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay. J Clin Virol. 2007;39:9-15.
25. Hira SK, Shroff HJ, Lanjewar DN, et al. The natural history of human immunodeficiency virus infection among adults in Mumbai. Natl Med J India. 2003;16:126-131.
26. Del Amo J, Petruckevitch A, Phillips A, et al. Disease progression and survival in HIV-1-infected Africans in London. AIDS. 1998;12:1203-1209.
27. Hogg RS, Strathdee SA, Craib KJ, et al. Lower socioeconomic status and shorter survival following HFV infection. Lancet. 1994;344:1120-1124.